Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, we focus on Revive Therapeutics, a pharmaceuticals company based out of Toronto, Canada, who is currently in Phase 3 clinical trials for its bucillamine Covid treatment, as well as developing psychedelic therapeutic solutions for aggressive breast cancer and treatment-resistant depression.

Enjoy!